Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG35484

IL18 Knockout CaSki Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Squamous cell carcinoma

CRISPR/Cas9-edited polyclonal knockout cell population of Ca Ski cervical carcinoma cells with disruption of the IL18 gene. Ca Ski is an HPV16-positive epithelial-like line, a key model for HPV-related cervical carcinogenesis. IL-18 is a pro-inflammatory cytokine that activates Th1 responses via IL-18R??/IL-18R?? and MyD88-dependent NF-??B and MAPK pathways, inducing IFN-?? and other mediators. This polyclonal knockout model enables studies of IL-18 function in tumor immunity, inflammasome signaling, and cytokine networks in the cervical cancer microenvironment. Suitable for inhibitor screening, co-culture assays, and molecular profiling applications.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    CaSki

    Sex of Donor

    Female

    Age

    40 years

    Derived From Site

    Metastatic; Small intestine

    Gene Name

    IL18

    Gene Identifier

    NCBI Gene ID 3606

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The IL18 Knockout Ca Ski Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Ca Ski cervical carcinoma cell line, engineered for targeted disruption of the IL18 gene. This loss-of-function model provides a genetically heterogeneous population of cells with impaired IL-18 expression, enabling robust functional studies without clonal selection artifacts.

The Ca Ski host cell line is an epithelial-like, adherent line originally isolated from a metastatic site of a cervical squamous cell carcinoma. It maintains an integrated HPV16 genome, establishing it as a widely used model for human papillomavirus-associated cervical carcinogenesis. Its well-characterized HPV-positive status renders it particularly relevant for investigating oncogenic virus?Chost interactions and the role of inflammatory mediators in cervical malignancy.

IL-18 is a potent pro-inflammatory cytokine that is synthesized as an inactive precursor and classically activated through proteolytic cleavage by caspase-1 within the NLRP3 inflammasome complex. Upon secretion, mature IL-18 engages the heterodimeric receptor composed of IL-18R?? and IL-18R??, leading to recruitment of the adaptor protein MyD88. This triggers downstream signaling cascades involving IRAK4, IRAK1, TRAF6, TAK1, and subsequently the activation of NF-??B and MAPK pathways, including JNK and p38. These events culminate in the transcriptional induction of IFN-??, TNF-??, chemokines such as CCL2 and CXCL10, and other inflammatory mediators, thereby driving Th1-type immune responses and modulating anti-tumor immunity.

In the context of cervical cancer, IL-18 is implicated in shaping the tumor microenvironment by influencing immune cell infiltration and cytokine networks. Ca Ski cells, as an HPV16-positive model, offer a physiologically relevant platform to dissect how IL-18 signaling intersects with viral oncogenesis and host inflammatory responses. Knockout of IL18 in this background permits the investigation of inflammasome-dependent and -independent roles of IL-18 in tumor cell proliferation, migration, and immune evasion, as well as its crosstalk with NF-??B and MAPK pathways.

Typical research applications include functional dissection of the NLRP3?Ccaspase-1?CIL-18 axis in cervical cancer, screening of small-molecule inhibitors targeting IL-18 signaling, and transcriptomic or proteomic profiling of IL-18-dependent gene networks. Compatible assays range from ELISA and Western blotting for IL-18 and downstream effectors, to caspase-1 activity measurements, NF-??B luciferase reporter assays, RT-qPCR for IFN-?? and inflammatory cytokines, tumor?Cimmune cell co-culture systems, Transwell migration/invasion assays, and multiplex cytokine bead arrays. For further technical details or ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)